Trade Mark Journal No.2026/024 12 June 2026

UK00004393854 28 May 2026 (5)

liquistal

Class 5: Pharmaceutical preparations; filled syringes for medical purposes [containing pharmaceuticals]; pharmaceutical preparations for the treatment of pubertas praecox; pharmaceutical preparations for the treatment of cancer of the prostate gland; pharmaceutical preparations for the treatment of breast cancer prior to menopause; pharmaceutical preparations for the treatment of hypermenorrhea; pharmaceutical preparations for the treatment of endometriosis; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the suppression of hormones; pharmaceutical preparations, namely, hormones for medical purposes.

Chong Kun Dang Pharmaceutical Corp.

Representative: Withers & Rogers LLP